In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 28 for your search:
Drug:  plerixafor
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Health services research, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Plerixafor-UF01, NCT01339572

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC12482, MOZ14409, U1111-1131-0145, NCT01767714

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-273, NCT00903968

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 2009-0536, NCT01160354

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 60
Sponsor: Other
Protocol IDs: SPON 845-10, 2010-021444-18, 10/MRE09/27, NCT01236144

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: DFI12860, 2010-019340-40, MOZ15609, NCT01288573

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: PLERIFLAG, NCT01435343

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120003, 12-C-0003, NCT01468311

9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: BRN0023, NCI-2013-02012, P30CA124435, NCT01977677

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: WCI1671-09, NCT01095757

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 18
Sponsor: Other
Protocol IDs: CHU-0082, NCT01225419

12.

Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 30
Sponsor: Other
Protocol IDs: SC001, NCT01403896

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 120074, 12-C-0074, NCT01547806

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: HAP3R, NCT01621477

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 09-PLEX, NCT01696461

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 12-388, NCT01746173

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARD12858, MOZ23510, 2011-004783-30, NCT01753453

18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-0150 / 201101810, NCT01065129

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2097.00, NCI-2011-00202, P30CA015704, NCT01331018

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-329, MAMO0909-6, NCT01339039

21.

Phase: Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 1104011617, NCT01352650

22.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: Primal study, NCT01455025

23.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Plerixafor, NCT01610999

24.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GCO # 09-0824, NCT01042717

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 09-0756-C, NCT01141543
1   
New Search